Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10

Nature Immunology

Volumn 8, Issue 9, 2007, Pages 931-941

  Maynard, Craig L ^a,b   Harrington, Laurie E ^a   Janowski, Karen M ^a   Oliver, James R ^a   Zindl, Carlene L ^b   Rudensky, Alexander Y ^c   Weaver, Casey T ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; INTESTINE LYMPHATIC TISSUE; LARGE INTESTINE; LIVER; LUNG; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SMALL INTESTINE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CELL DIFFERENTIATION; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-10; INTESTINES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEYER'S PATCHES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 34548131112     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1504     Document Type: Article

References (55)

1. Fiorentino, D.F., Bond, M.W. & Mosmann, T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095 (1989).
2. Fiorentino, D.F. et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146 3444-3451 (1991).
3. Moore, K.W., de Waal Malefyt, R., Coffman, R.L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765 (2001).
4. + Tregs: Limiting collateral damage. J. Clin. Invest. 114, 1372-1378 (2004).
5. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
6. Sellon, R.K. et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66, 5224-5231 (1998).
7. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med. 184, 241-251 (1996).
8. Asseman, C., Mauze, S., Leach, M.W., Coffman, R.L. & Powrie, F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004 (1999).
9. Roers, A. et al. T cell-specific Inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin Irritation. J. Exp. Med. 200, 1289-1297 (2004).
10. Izcue, A., Coombes, J.L. & Powrie, F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212, 256-271 (2006).
11. Zheng, Y. & Rudensky, A.Y. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8, 457-462 (2007).
12. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306 (2001).
13. Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756-763 (2002).
14. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
15. Hori, S., Nomura, T. & Sakaguichi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
16. Williams, L.M. & Rudensky, A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression at Foxp3. Nat. Immunol. 8, 277-284 (2007).
17. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302 (2000).
18. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
19. Tone, M. et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA 100, 15059-15064 (2003).
20. Weaver, C.T., Harrington, L.E., Mangan, P.R., Gavrieli, M. & Murphy, K.M. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677-688 (2006).
21. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742 (1997).
22. Wakkach, A. et al. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18, 605-617 (2003).
23. Groux, H. Type 1 T-regulatory cells: Their role in the control of immune responses. Transplantation 75, 8S-12S (2003).
24. + regulatory T cells. J. Immunol. 172, 5986-5993 105, 1162-1169 (2004).
25. reg cells. Blood 105, 1162-1169 (2004).
26. Fontenot, J.D. et al. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22, 329-341 (2005).
27. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5, 1461-1471 (1993).
28. + T cells during cure of colitis. J. Immunol. 177, 5852-5860 (2006).
29. + effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J. Exp. Med. 197, 181-193 (2003).
30. Levings, M.K. et al. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166, 5530-5539 (2001).
31. Cong, Y., Weaver, C.T., Lazenby, A. & Elson, C.O. Bacterial-reactive T regulatory cells inhibit pathogenic immune respondes to the enteric flora. J. Immunol. 169, 6112-6119 (2002).
32. Rońcarolo, M.G. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50 (2006).
33. Groux, H. et al. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 162, 1723-1729 (1999).
34. Belkaid, Y. et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194, 1497-1506 (2001).
35. Akbari, O. et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8, 1024-1032 (2002).
36. Stock, P. et al. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper reactivity. Nat. Immunol. 5, 1149-1156 (2004).
37. - Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204, 285-207 (2007).
38. - Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204, 273-283 (2007).
39. Weiner, H.L. Oral toleranoe: Immune mechanisms and the generation of Th3-type TGF-β-secrefing regulatory cells. Microbes Infect. 3 947-954 (2001).
40. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
41. Li, M.O., Sanjabi, S. & Flavell, R.A. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25, 455-471 (2006).
42. Marie, J.C., Liggitt, D. & Rudensky, A.Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity 25, 441-454 (2006).
43. Kitani, A. et al. Transforming growth factor (TGF -β1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-β1-mediated fibrosis. J. Exp. Med. 198, 1179-1188 (2003).
44. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17- producing T cells. Immunity 24 179-189 (2006).
45. H17 lineage. Nature 441, 231-234 (2006).
46. H17 and regulatory T cells. Nature 441, 235-238 (2006).
47. Van Montfrans, C. et al. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model. Gastroenterology 123, 1865-1876 (2002).
48. + regulatory T cells. J. Exp. Med. 201, 1061-1067 (2005).
49. Poussier, P., Ning, T., Banerjee, D. & Julius, M. A unique subset of self-specific intraintestinal T cells maintains gut integrity. J. Exp. Med. 195, 1491-1497 (2002).
50. + T cells in the control of inflammation. J. Immunol. 171, 5018-5026 (2003).
51. Mucida, D. et al. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115, 1923-1933 (2005).
52. Defrance, T. et al. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175, 671-682 (1992).
53. Cazac, B.B. & Roes, J. TGF-β receptor controls B cell responsiveness and induction of lgA in vivo. Immunity 13, 443-451 (2000).
54. Brooks, D.G., Teyton, L., Oldstone, M.B. & McGavern, D.B. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 79, 10514-10527 (2005).
55. Kamanaka, M. et al. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25, 941-952 (2006).